Udwadia ZF, Barkate H, Patil S, Rangwala S, et al. Response to the comments received on article "Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial" by Udwadia et a Int J Infect Dis 2021;105:686-687.
PMID: 33601032